News and Press

Press releases

2024

2024-09-19 08:30 The last day of trading in warrants of series TO 1 is on the 24th of September 2024

The 24th of September 2024 is the last day of trading in warrants of series TO 1, which were issued in connection with Diagonal Bio AB's ("Diagonal Bio"...

2024-09-12 08:30 The exercise period for warrants of series TO 1 commences today

Today is the first day for the exercise of Diagonal Bio AB's ("Diagonal Bio" or "the Company") warrants of series TO 1 ("TO 1") which were issued in connection...

2024-09-11 09:00 The exercise price for warrants of series TO 1 has been set to SEK 0,05 per new share Regulatory

Diagonal Bio AB ("Diagonal Bio" or "the Company") hereby announces that the exercise price for the warrants of series TO 1 (”TO 1”), which were issued...

2024-09-06 11:30 Diagonal Bio announces successful external validation of LAMPlify® for respiratory viruses in horses Regulatory MAR

Diagonal Bio AB (publ) (“Diagonal Bio” and “the Company”) announces that its diagnostic tool, LAMPlify® has undergone a successful external validation...

2024-08-22 08:00 Diagonal Bio AB Second Quarter Report (Q2 2024) Regulatory MAR

“In the second quarter of 2024, we have made advancements, particularly within the equine healthcare sector (horse veterinary clinics) where our connections...